MedPath

Platelet Rich Plasma Following Hysteroscopic Adhesolysis

Not Applicable
Completed
Conditions
Intra-uterine Adhesions
Registration Number
NCT03881215
Lead Sponsor
Ain Shams University
Brief Summary

Platelet Rich Plasma Following Hysteroscopic Adhesolysis: A Randomized Clinical Trial

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Age: 18-40 years
  • Grade III intra-uterine adhesions
Exclusion Criteria
  • Age < 18 or > 40 years.
  • Hb < 11 g/dL, platelets < 150.000/mm3.
  • Patient taking anticoagulant.
  • Patient taking NSAID in the 10 days before procedure.
  • Any significant comorbidity or psychiatric disorder that would compromise patient's consent.
  • Active cervical or uterine infection.
  • Undiagnosed genital bleeding.
  • pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of adhesion recurrence3 months

recurrence of severe intra-uterine adhesions

Secondary Outcome Measures
NameTimeMethod
Days of menses3 months

Number of days of menstrual cycle following operation

Amount of menses3 months

Number of sanitary pads changed during each menstrual cycle

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital

🇪🇬

Cairo, Egypt

Ain Shams University Maternity Hospital
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.